EMRELIS vs VINORELBINE TARTRATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. EMRELIS and VINORELBINE TARTRATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EMRELIS	VINORELBINE TARTRATE
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TELISOTUZUMAB VEDOTIN-TLLV	VINORELBINE TARTRATE
Manufacturer	Abbvie	Rising
Dosage forms	Injectable	Injectable
Drug class	—	Vinca Alkaloid
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

emrelis vinorelbine tartrate

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

TELISOTUZUMAB VEDOTIN-TLLV

VINORELBINE TARTRATE

Manufacturer

Abbvie

Rising

Dosage forms

Injectable

Drug class

—

Vinca Alkaloid

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

Frequently asked questions

Which is better-rated, Emrelis or Vinorelbine Tartrate?

Emrelis and Vinorelbine Tartrate are tied at 3.6 out of 5 by our independent rating.

What is the difference between Emrelis and Vinorelbine Tartrate?

Emrelis contains Telisotuzumab Vedotin-Tllv, while Vinorelbine Tartrate contains Vinorelbine Tartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.